Results 141 to 150 of about 75,323 (218)

Capecitabine maintenance after radiofrequency ablation: A preventive strategy for lung oligometastases from colorectal cancer. [PDF]

World J Gastroenterol
Giangregorio F.
europepmc   +1 more source

Setting the record straight: Activity of gemcitabine monotherapy for breast cancer - Reply [PDF]

, 2004
Heinemann, Volker
core   +1 more source

Pembrolizumab-Induced Colitis With Concurrent Capecitabine in Triple-Negative Breast Carcinoma: A Case Report. [PDF]

Cureus
Kafka W, Frandah W, Diks J.
europepmc   +1 more source

A case of descending colon cancer achieving a complete response with preoperative capecitabine plus oxaliplatin therapy following colorectal stenting. [PDF]

J Surg Case Rep
Mitsuhara C, Nishihara M, Ozawa N, Asano S.   +3 more
europepmc   +1 more source

Dual Cardiotoxicity of Capecitabine: Coronary Vasospasm and QT Prolongation in a Patient With Gastric Adenocarcinoma. [PDF]

JACC Case Rep
Dominguez-Linares A, Nieto-Dolores AK, Ayala-Bustamante LE, Valencia Hernandez HA, Ruiz-Mori E, Gonzalez-Trejo A, Guerra EC, Acosta-Gutierrez GH, Ponce-Acosta C, Espinola-Zavaleta N.   +9 more
europepmc   +1 more source

Risk of myocardial infarction following capecitabine treatment in patients with gastrointestinal cancer - a nationwide registry-based study. [PDF]

Cardiooncology
Shanmuganathan JWD, Kragholm K, Yonis H, Schou M, Torp-Pedersen C, Poulsen LØ, Pareek M, Gislason G, Køber L, Nielsen D, El-Galaly TC, Søgaard P, Mamas MA, Freeman P.   +13 more
europepmc   +1 more source

Adjuvant tislelizumab, lenvatinib, and capecitabine for resected biliary tract cancer: a prospective phase II trial. [PDF]

BMC Med
Feng Y, Zhang N, Zhao YM, Pan Q, Mao AR, Zhu WP, Zhang T, Wang L.   +7 more
europepmc   +1 more source

Intratumoral microbiota-derived S1P sensitizes the combination therapy of capecitabine and PD-1 inhibitors. [PDF]

iScience
Dai CS, Qi TT, Shang HL, Xie RH, Liu H, Liu ZM, Cui YM, Zhang YH.   +7 more
europepmc   +1 more source

Primary Tumor Size and Tumor-Vessel Interface Following Capecitabine and Temozolomide for Pancreatic Neuroendocrine Tumor. [PDF]

Curr Oncol
Guo J, Lewis KA, Prakash L, Bhosale P, Morani A, Katz MHG, Tzeng CD, Ikoma N, Snyder R, Kim MP, Chandrasekharan C, Dasari A, Yao JC, Lee JE, Maxwell JE, Halperin DM.   +15 more
europepmc   +1 more source